ABIVAX
A French Société anonyme (corporation) with a capital of 629,308.18 euros
Registered office: 7-11, boulevard Haussmann
75009 Paris (France)
Paris Trade and Companies Registry no. 799 363 718
Annual Ordinary and Extraordinary General Shareholders' Meeting on 30 May 2024
Breakdown of the vote by resolution
Number of shares with voting rights | 61 012 501 | |||||||||||||
Total number of votes | 68 032 059 | |||||||||||||
Number of shareholders present, represented or voting by post | 132 | |||||||||||||
Number of shares present, represented or voting by post | 49 815 120 | |||||||||||||
Number of votes present, represented or voting by post | 55 747 104 | |||||||||||||
Participation rate | 81.65% | |||||||||||||
For | Against | Abstain | ||||||||||||
Ordinary General Shareholders' Meeting | Votes | % | Votes | % | Votes | % | ||||||||
1. | Approval of the Company's financial statements for | the financial | year | 55 730 237 | 99.999% | 494 | 0.001% | 16 373 | 0.029% | |||||
ended 31 December 2023 | ||||||||||||||
2. | Approval of the Company's consolidated financial | statements for | the | 55 730 237 | 99.999% | 494 | 0.001% | 16 373 | 0.029% | |||||
financial year ended 31 December 2023 | ||||||||||||||
3. | Allocation of the income for the financial year ended 31 December 2023 | 55 746 610 | 99.999% | 494 | 0.001% | 0 | 0.000% | |||||||
4. | Approval of the agreements referred to Articles L. 225-38 et seq. of the | 44 083 418 | 79.078% | 11 663 486 | 20.922% | 200 | 0.001% | |||||||
French Commercial Code (Code de commerce) | ||||||||||||||
5. | Ratification of the cooptation of a Director (Troy Ignelzi) | 55 707 725 | 99.930% | 39 179 | 0.070% | 200 | 0.001% | |||||||
6. | Ratification of the cooptation of a Director (June (Lee) Kim) | 55 707 725 | 99.930% | 39 179 | 0.070% | 200 | 0.001% | |||||||
7. | Ratification of the cooptation of a Director (Camilla Soenderby) | 55 746 324 | 99.999% | 580 | 0.001% | 200 | 0.001% | |||||||
8. | Approval of the compensation items mentioned in Article L. 22-10-9 I of | |||||||||||||
the French Commercial Code, pursuant to Article L. 22-10-34 of the French | 54 504 460 | 97.771% | 1 242 444 | 2.229% | 200 | 0.001% | ||||||||
Commercial Code | ||||||||||||||
For | Against | Abstain | |||||||
Ordinary General Shareholders' Meeting | Votes | % | Votes | % | Votes | % | |||
9. | Approval of the compensation items paid during, or allocated for, the | ||||||||
financial year 2023 to Ms. Corinna zur Bonsen-Thomas as Chair of the | 55 594 011 | 99.726% | 152 893 | 0.274% | 200 | 0.001% | |||
Board of Directors by interim | |||||||||
10. | Approval of the compensation items paid during, or allocated for, the | ||||||||
financial year 2023 to Mr. Marc de Garidel as Chairman of the Board of | 44 137 875 | 79.175% | 11 609 029 | 20.825% | 200 | 0.001% | |||
Directors and Chief Executive Officer | |||||||||
11. | Approval of the compensation items paid during, or allocated for, the | 44 056 505 | 79.030% | 11 690 399 | 20.970% | 200 | 0.001% | ||
financial year 2023 to Mr. Hartmut Ehrlich as Chief Executive Officer | |||||||||
12. | Approval of the information on corporate officers' compensation included | ||||||||
in the corporate governance report and referred to in Article L.22-10-9 I. | 54 655 224 | 98.042% | 1 091 680 | 1.958% | 200 | 0.001% | |||
of the French Commercial Code | |||||||||
13. | Approval of the compensation policy applicable to the Chairman of the | 55 744 775 | 99.996% | 2 129 | 0.004% | 200 | 0.001% | ||
Board of Directors | |||||||||
14. | Approval of the compensation policy applicable to the Chief Executive | 44 256 935 | 79.389% | 11 489 969 | 20.611% | 200 | 0.001% | ||
Officer | |||||||||
15. | Approval of the compensation policy applicable to the Board members | 55 594 011 | 99.726% | 152 893 | 0.274% | 200 | 0.001% | ||
16. | Authorization to be granted to the Board to purchase the Company's own | 44 593 043 | 79.992% | 11 153 861 | 20.008% | 200 | 0.001% | ||
shares | |||||||||
For | Against | Abstain | ||||||||
Extraordinary General Shareholders' Meeting | ||||||||||
Votes | % | Votes | % | Votes | % | |||||
17. | Authorization to the Board of Directors to reduce share capital by | 55 444 282 | 99.457% | 302 622 | 0.543% | 200 | 0.001% | |||
cancelling treasury shares | ||||||||||
18. | Delegation of authority to the Board of Directors to carry out a capital | |||||||||
increase by issuing shares, equity securities giving access to other equity | ||||||||||
securities or giving the right to the allocation of debt securities and/or | 44 183 811 | 79.258% | 11 563 093 | 20.742% | 200 | 0.001% | ||||
securities giving access to equity securities, maintaining preferential | ||||||||||
subscription rights | ||||||||||
19. | Delegation of authority to the Board of Directors to carry out a capital | |||||||||
increase by issuing shares, equity securities giving access to other equity | 44 034 819 | 78991% | 11 712 085 | 21.009% | 200 | 0.001% | ||||
securities or giving the right to the allocation of debt securities and/or | ||||||||||
securities giving access to equity securities, with cancellation of the |
For | Against | Abstain | ||||||||
Extraordinary General Shareholders' Meeting | Votes | % | Votes | % | Votes | % | ||||
preferential subscription rights by way of an offer to the public, and with | ||||||||||
the ability to confer a right of priority | ||||||||||
20. | Delegation of authority to the Board of Directors to carry out a capital | |||||||||
increase by issuing shares, equity securities giving access to other equity | ||||||||||
securities or giving the right to the allocation of debt securities and/or | 44 035 900 | 78.993% | 11 711 004 | 21.007% | 200 | 0.001% | ||||
securities giving access to equity securities, with cancellation of the | ||||||||||
preferential subscription rights in favor of a specific category of persons | ||||||||||
21. | Delegation of authority to the Board of Directors to carry out a capital | |||||||||
increase, within the limit of 20% of the share capital per year, by issuing | ||||||||||
shares, equity securities conferring access to other equity securities or | ||||||||||
conferring the right to an allotment of debt securities and/or securities | 44 629 521 | 80.057% | 11 117 383 | 19.943% | 200 | 0.001% | ||||
conferring access to equity securities, with cancellation of the preferential | ||||||||||
subscription rights by way of an offer to qualified investors or a restricted | ||||||||||
group of investors, within the meaning of Article L. 411-2, paragraph II, of | ||||||||||
the French Monetary and Financial Code (Code monétaire et financier) | ||||||||||
22. | Authorization to be granted to the Board of Directors in accordance with | |||||||||
Articles L. 22-10-52, paragraph 2, and R. 22-10-32 of the French | ||||||||||
Commercial Code to set the issue price of the shares, equity securities | ||||||||||
conferring access to other equity securities or conferring the right to an | 44 223 534 | 79.329% | 11 523 370 | 20.671% | 200 | 0.001% | ||||
allotment of debt securities and/or securities conferring access to equity | ||||||||||
securities, with cancellation of the preferential subscription rights, for the | ||||||||||
delegations of authority set forth in the 19th and 21st resolutions | ||||||||||
23. | Delegation of authority to the Board of Directors to carry out a capital | |||||||||
increase by issuing shares, equity securities conferring access to other | ||||||||||
equity securities or conferring the right to an allotment of debt securities | ||||||||||
and/or securities conferring access to equity securities, with cancellation of | 44 074 499 | 79.062% | 11 672 405 | 20.938% | 200 | 0.001% | ||||
the preferential subscription rights in favor of certain categories of | ||||||||||
investors within the framework of an equity financing agreement in the | ||||||||||
United States stock market known as an "At-The-Market" or "ATM | ||||||||||
Program" | ||||||||||
24. | Delegation of authority to the Board of Directors to increase the number of | |||||||||
shares to be issued in the event of a capital increase with or without | 44 309 207 | 79.483% | 11 437 697 | 20.517% | 200 | 0.001% | ||||
preferential subscription rights | ||||||||||
25. | Delegation of authority to the Board of Directors to increase capital by | 55 626 350 | 99.784% | 120 554 | 0.216% | 200 | 0.001% | |||
capitalizing premiums, reserves, profits or other items | ||||||||||
For | Against | Abstain | ||||||||
Extraordinary General Shareholders' Meeting | Votes | % | Votes | % | Votes | % | ||||
26. | Delegation of authority to the Board of Directors to issue shares and | |||||||||
securities leading to a capital increase in consideration of non-cash | 44 073 640 | 79.060% | 11 673 264 | 20.940% | 200 | 0.001% | ||||
contributions | ||||||||||
27. | Delegation of authority to the Board of Directors to issue shares and | |||||||||
securities entailing a capital increase in the event of a public exchange offer | 44 035 041 | 78.991% | 11 711 863 | 21.009% | 200 | 0.001% | ||||
initiated by the Company | ||||||||||
28. | Setting of the overall limits on the amount of the issues carried out pursuant | 55 550 917 | 99.648% | 195 987 | 0.352% | 200 | 0.001% | |||
to the delegations granted | ||||||||||
29. | Authorization to the Board of Directors to grant share subscription and/or | |||||||||
purchase options ("Options"), with cancellation of the shareholders' | 44 009 664 | 78.945% | 11 737 240 | 21.055% | 200 | 0.001% | ||||
preferential subscription rights in favor of a specific category of persons | ||||||||||
30. | Delegation of authority to the Board of Directors to issue and allot ordinary | |||||||||
share warrants ("Warrants"), with cancellation of the shareholders' | 44 049 263 | 79.017% | 11 697 641 | 20.983% | 200 | 0.001% | ||||
preferential subscription rights in favor of a specific category of persons | ||||||||||
31. | Authorization to the Board of Directors to allot free shares, whether | |||||||||
existing or to be issued ("Free Shares"), with cancellation of the | 44 165 912 | 79.226% | 11 580 992 | 20.774% | 200 | 0.001% | ||||
shareholders' preferential subscription rights in favor of a specific category | ||||||||||
of persons | ||||||||||
32. | Setting of the overall limits on the amount of the issues carried out pursuant | |||||||||
to the authorizations to grant Options and Free Shares and the delegations | 55 704 647 | 99.924% | 42 257 | 0.076% | 200 | 0.001% | ||||
of authority in order to issue Warrants | ||||||||||
33. | Delegation of authority to the Board of Directors to carry out a capital | |||||||||
increase by issuing shares or securities conferring access to the Company's | 32 655 576 | 58.578% | 23 091 328 | 41.422% | 200 | 0.001% | ||||
capital restricted to members of a company savings plan, with cancellation | ||||||||||
of the shareholders' preferential subscription rights in favor thereof | ||||||||||
For | Against | Abstain | ||||||||
Ordinary General Shareholders' Meeting | ||||||||||
Votes | % | Votes | % | Votes | % | |||||
34. | Powers for formalities | 55 746 410 | 99.999% | 494 | 0.001% | 200 | 0.001% | |||
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Abivax SA published this content on 04 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 June 2024 20:29:48 UTC.